Add another Item to this comparison
Add Item
Basic Information |
Generic Name |
|
Amphetamine And Dextroamphetamine |
vs |
Methylphenidate |
|
Class |
|
Cns Stimulants |
vs |
Cns Stimulants |
|
Prescription Generic Available |
|
Yes |
vs |
No |
|
Pregnancy cat. |
|
C(us) |
vs |
C(us) |
|
Approved Age |
|
3 And Older |
vs |
6 And Older |
|
Legal Status |
|
Schedule I (ca) Schedule Ii (us) |
vs |
Schedule Ii (us) |
|
WADA Category |
|
S6 - Stimulants |
vs |
S6 - Stimulants |
|
Dependence Liability |
|
High |
vs |
Moderate |
|
Excretion |
|
Urinary |
vs |
|
|
Possible Side Effects |
|
Some Loss Of Appetite, Weight Loss, Sleep Problems, Irritability, Tics. |
vs |
Some Loss Of Appetite, Weight Loss, Sleep Problems, Irritability, Tics. |
|
Dosage, Usage and Forms |
Routes (of administration) |
|
(medical) Oral, Insufflated, Intravenous |
vs |
Oral |
|
Dosage |
|
5–30 Mg Bid Or 5–60 Mg Q
Am |
vs |
20–60 Mg Q Am |
|
Maximum daily dose |
|
60 mg |
vs |
60 mg |
|
Duration |
|
Intermediate-acting |
vs |
Long-acting |
|
Duration - time |
|
4-8 H |
vs |
9-12 H |
|
Chemical Data |
Molecular mass (g/mol) |
|
135.21 G/mol |
vs |
269.77 G/mol |
|
Half Life |
|
10 Hours |
vs |
6.8 Hours |
|
Formula |
|
C9h13n |
vs |
C14h19no2•hcl |
|
Bioavailability |
|
Nasal 75%; Rectal 95-99%; Intravenous 100% |
vs |
30 % |
|
Protein binding |
|
15-40% |
vs |
15 % |
|
Metabolism |
|
Hepatic |
vs |
Hepatic |
|
Compare Adderall vs Metadate CD ADHD Medications
cancel